Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 858 results for "ema"

MorphoSys's MOR208 Program Receives Positive Opinion for Orphan Medicinal Product Designation from EMA for DLBCL

EMA Backs MorphoSys' Orphan Application For MOR208 In DLCBL

By Estel Grace Masangkay MorphoSys , a company specializing in developing therapeutic antibodies, announced that it has received the positive opinion of the European Medicines Agency for the Orphan Medicinal Product Designation application of its ... Bioresearch Online, 11 hours ago

1,659 images for ema

Pharmaceutical Journal, 5 hours ago
Pharma Letter, 2 days ago
Paste Magazine, 7 hours ago
Live Production, 6 days ago
Hollywood Reporter, 2 days ago
Jewish Journal of Greater Los Angeles, 1 day ago
Slate Magazine, 5 days ago
She Knows, 1 day ago
Elgin Courier News, 2 days ago
MYLAUNCHPAD, 5 days ago
Pharma Letter

Jury Still Out on Potential Ebola Treatments, EMA Says

The jury is still out on the safety or efficacy of experimental therapies for Ebola virus disease, for now, the European Medicines Agency (EMA) said in the first interim report on the subject, released December 16. "Treatments for patients ...
 American Journal of Public Health19 hours ago EMA comments on experimental Ebola treatments  MedNous23 hours ago Evidence still lacking for Ebola treatments, concludes EMA  Pharmacy Magazine1 day ago BRIEF-EMA says experimental Ebola treatments still at early stage of development  Reuters2 days ago

PhUSE Registered as Member of EMA Stakeholder Database

Being part of the EMA stakeholder database has several advantages for PhUSE and PhUSE members. PhUSE is able to be identified by the EMA in relation to any issue under discussion by the EMA and for which interaction with the stakeholder is ...
 Digital Journal21 hours ago Orphans' plight moves Ema, 6, to volunteer  New Zealand Herald6 days ago

Dramatically Evolving Big Data

November 2014 EMA Analyst's Corner ENTERPRISE MANAGEMENT ASSOCIATES ® Analyst's Corner December 2014 EMA Analyst's Corner: The world of big data and big data applications are evolving at a rapid pace. Just a few years ago it was enough to ...
 Enterprise Management Associates1 hour ago EMA: Busy times for FPSO contractors with new awards on the way  Offshore oil and gas5 days ago

News and press releases: Focus on innovative medicines for animals

16/12/2014 Focus on innovative medicines for animals New EMA expert group to support veterinary novel therapies The European Medicines Agency's Committee for Medicinal Products for Veterinary Use (CVMP) has established a new Ad Hoc ...
 European Medicines Agency2 days ago 10 Up-and-Coming Healthcare Medical Innovations  Bioscience Technology Online5 hours ago

Regulatory information - EMA releases practical guidance on access-to-documents requests

02/10/2014 Publication of clinical reports EMA adopts landmark policy to take effect on 1 January 2015 The European Medicines Agency (EMA) has decided to publish the clinical reports that underpin the decision-making on medicines.
 European Medicines Agency3 days ago

Bayer submits marketing authorization application for hemophilia A drug to EMA

LEOPOLD I is a randomized, open-label, crossover study in males aged 12-65 years. The objectives were to demonstrate the efficacy and safety of BAY 81-8973 when used as prophylaxis, for the treatment of bleeding episodes, and for maintaining ...
 Individual.com6 days ago Bayer Submits Biologics License Application for BAY 81-8973 for the Treatment of Hemophilia A in Adults and Children  Minyanville1 day ago Synageva BioPharma Announces Active Investigational New Drug Application For SBC-103 For The Treatment Of Mucopolysaccharidosis IIIB  PipelineReview3 days ago Ultragenyx Announces Initiation of Phase 3 Study of Recombinant Human Beta-Glucuronidase in Mucopolysaccharidosis Type 7  PipelineReview3 days ago
BirdLife International

European Medicines Agency asks the European Commission to address vulture-killing drug

The European Medicines Agency (EMA) has supported the arguments expressed by BirdLife regarding therisk that the veterinary use of the drug diclofenac represents to vultures. In their scientific opinion on diclofenacand vultures, EMA is asking the ...
 BirdLife International3 days ago EMA upgrades conflict of interest controls  Manufacturing Chemist3 days ago Effectiveness and pharmacoepidemiology studies - EMA/2014/50/RE  European Medicines Agency6 days ago GlaxoSmithKline seeks EMA approval for extended indication for ambrisentan to treat PAH  Pharmaceutical Business Review6 days ago

Regulatory update - EMA encourages companies to submit type-I variations for 2014 by end of...

06/10/2014 Information on suspected side effects of nationally authorised medicines now available through a single website EMA encourages patients to report suspected side effects As of today, European citizens can obtain information ...
 European Medicines Agency6 days ago
Business Standard

GVK Bio may redo studies doubted by European drug regulator

ean Medicines Agency (EMA), a top executive said here today. Maintaining that recent development is a 'body-blow', GVK Biosciences Chief Executive Officer Manni Kantipudi said the drug studies have come to a standstill at the Hyderabad facility as requested ...
 Business Standard1 week ago EU members fault GVK Bio clinical trials, suspend marketing approvals for medicines  Business Standard1 week ago GVK Bio under scanner of European Drug Regulator  Business Standard2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less